SAGE Therapeutics Inc
SWB:SG7
SAGE Therapeutics Inc
SWB:SG7
Price:
7.598
EUR
1.12%
Market Cap:
€457.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
SAGE Therapeutics Inc
SWB:SG7
|
US |
|
Ki-Star Real Estate Co Ltd
TSE:3465
|
JP |
|
C
|
Cyfuse Biomedical KK
TSE:4892
|
JP |
|
Nippon Telegraph and Telephone Corp
OTC:NTTYY
|
JP |
|
P
|
PennantPark Floating Rate Capital Ltd
F:22P
|
US |
|
NameSilo Technologies Corp
OTC:URLOF
|
CA |
|
E
|
Ecomembrane SpA
MIL:ECMB
|
IT |
|
Meituan
OTC:MPNGY
|
CN |
|
E
|
ExpreS2ion Biotech Holding AB
F:5JD
|
SE |
|
Q
|
QBeyond AG
XHAM:QBY
|
DE |
|
Ipsos SA
F:IPZ
|
FR |
|
Margaret Lake Diamonds Inc
F:M85
|
CA |
|
G
|
Genmab A/S
DUS:GE9
|
DK |
|
P
|
PG&E Corp
SWB:PCG
|
US |
|
S
|
SeaWorld Entertainment Inc
XMUN:W2L
|
US |
|
B
|
Beacon Minerals Ltd
ASX:BCN
|
AU |
|
F
|
Fortis Inc
SWB:12F
|
CA |
|
Willow Biosciences Inc
F:3D7
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SG7's stock price target?
Not Available
SG7 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for SAGE Therapeutics Inc?
Projected CAGR
57%
57%
The compound annual growth rate for Revenue over the next 3 years is 57%.
